In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Intuitive Surgical (ISRG – Research Report), with a price target of $250.00. The company’s shares closed last Tuesday at $216.79, close to its 52-week low of $186.83.
According to TipRanks.com, Biasio is a 4-star analyst with an average return of 6.6% and a 59.5% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Coherus Biosciences, and Boston Scientific.
Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $244.87, implying a 12.3% upside from current levels. In a report issued on July 15, Morgan Stanley also maintained a Hold rating on the stock with a $225.00 price target.
The company has a one-year high of $369.69 and a one-year low of $186.83. Currently, Intuitive Surgical has an average volume of 2.17M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Read More on ISRG:
- Treasury Wine Estates Limited (TSRYF) Gets a Buy Rating from Morgan Stanley
- Regis Resources Limited (RGRNF) Receives a Sell from Morgan Stanley
- Citigroup Upgrades Regis Resources Limited (RGRNF) to Hold
- Clear Sky Announces Appointment of Industry Veteran
- BMO Capital Remains a Buy on Boston Properties (BXP)